MediciNova, Inc.
MNOV
$1.51
$0.042.72%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -86.54% | -- | -- | -100.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -86.54% | -- | -- | -100.00% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -98.17% | -- | -- | -100.00% |
| SG&A Expenses | 16.62% | 11.71% | 7.42% | 4.54% | -10.29% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.78% | 24.19% | 15.07% | 16.29% | 2.92% |
| Operating Income | -11.62% | -35.47% | -26.49% | -28.03% | -12.60% |
| Income Before Tax | -16.65% | -44.66% | -32.70% | -28.89% | -8.20% |
| Income Tax Expenses | 83.33% | 83.33% | 83.33% | 83.33% | 7.14% |
| Earnings from Continuing Operations | -16.67% | -44.67% | -32.71% | -28.91% | -8.20% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.67% | -44.67% | -32.71% | -28.91% | -8.20% |
| EBIT | -11.62% | -35.47% | -26.49% | -28.03% | -12.60% |
| EBITDA | -11.65% | -35.56% | -26.56% | -28.08% | -12.60% |
| EPS Basic | -16.62% | -44.68% | -32.71% | -28.95% | -8.25% |
| Normalized Basic EPS | -16.70% | -44.62% | -32.68% | -28.85% | -8.17% |
| EPS Diluted | -15.29% | -42.40% | -30.75% | -30.75% | -8.20% |
| Normalized Diluted EPS | -16.70% | -44.62% | -32.68% | -28.85% | -8.17% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |